ProCE Banner Activity

Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy

Slideset Download

Download this slideset on the management of NTRK and RET-altered lung and thyroid cancer with targeted therapies.

Released: November 17, 2022

Begin Activity

Share

Faculty

Saad A. Khan

Saad A. Khan, MD

Assistant Professor of Medicine (Oncology)
Leader, Endocrine Cancers Research Group
Stanford Cancer Institute
Stanford University
Stanford, California

Sandip P. Patel

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc, Blueprint Medicines and Genentech, a member of the Roche Group, and Lilly.

Bayer HealthCare Pharmaceuticals Inc.

Blueprint Medicines and Genentech, a member of the Roche Group

Lilly

Partners

American Society for Clinical Pathology

ProCE Banner

Partnered with the American Society for Clinical Pathology.